🇺🇸

US SEC Filing Intelligence

· daily

HHS & Healthcare Contracts Intelligence — August 07, 2026

During the period August 7, 2026, a single HHS contract worth $155.8 million was awarded to Merck Sharp & Dohme LLC for ERVEBO procurement, a civilian biodefense and pandemic preparedness action. The contract is entirely civilian (0% defense-related) and carries a moderate signal strength of 6/10 due to the firm-fixed-price structure and multi-year option uncertainty. The highest-conviction signal is Merck’s long-term revenue visibility from a 10-year base-plus-options vehicle, but investors should watch execution risk if production costs exceed the fixed price and the timing of option exercises totaling $17.8 million.

1 total filings
· daily

New Federal Contractors — August 07, 2026

This digest of 7 new federal contracts, totaling $1.26 billion, reveals a pronounced civilian agency tilt, with only 2 of 7 awards being defense-related. The dominant theme is sustained U.S. government investment in health security and biodefense, led by two substantial awards to Merck Sharp & Dohme LLC from HHS/BARDA totaling $392.1 million. The highest-conviction signal is Merck's dual contract wins, which provide long-term revenue visibility through 2034 and align with enduring pandemic preparedness priorities. A key risk is the concentration of awards to a single entity (Merck) and the absence of defense-related signals, which may limit exposure to growth in the defense budget. Investors should watch for the exercise of Merck's $72.9 million in combined contract options as a key catalyst.

7 total filings
· daily

Significant Contract Modifications ($10M+) — August 07, 2026

The 7 contracts analyzed, valued at $1.26 billion aggregate, are overwhelmingly civilian-agency awards (5 of 7), with the Department of Health and Human Services (HHS) emerging as the dominant spender via two Merck Sharp & Dohme contracts totaling $392.2 million for biodefense and pharmaceutical procurement. The highest-conviction bullish signal is Merck's dual HHS/BARDA awards, reflecting durable government biodefense funding, while the sole defense-related contract—Whitney Bradley & Brown's $108 million GSA delivery order—is neutral but exposes Serco Limited's subsidiary to firm-fixed-price execution risk. Key risks include the expiration of the ARCTIC SLOPE Technical Services $388.5 million NASA contract (fully performed, zero future upside) and concentration at HHS. Investors should monitor option exercises on Merck's BARDA contract through 2034 and Suffolk Construction's execution of a fixed-price $88.2 million VA boiler replacement project.

7 total filings
· daily

Contract Deobligations Alert — August 07, 2026

The seven contracts analyzed, totaling $1.26 billion, are overwhelmingly civilian (5 of 7), with the Department of Health and Human Services (HHS) and its BARDA agency dominating the award value via two large contracts to Merck Sharp & Dohme LLC worth $392.2 million combined. The highest-conviction signal is the dual Merck awards, which provide long-term, low-risk revenue visibility from a key biodefense agency, though the cost-plus structure on the larger award limits profit upside. A key risk is the concentration of awards to Merck, which creates single-entity dependency for the biodefense theme, and the completed nature of the largest contract (Arctic Slope Technical Services) means its revenue is non-recurring.

7 total filings
· daily

Contract Option Exercises — August 07, 2026

The seven contract awards totaling $1.26 billion present a predominantly civilian-focused opportunity set, with only two defense-related awards (28.6% of count) and a heavy concentration in health and infrastructure agencies. The most compelling signal is Merck Sharp & Dohme's two HHS/BARDA awards totaling $392.1 million for pharmaceutical R&D and ERVEBO procurement, reflecting sustained biodefense spending post-COVID. The highest-conviction single award is SENTURE LLC's $105.6 million DOT contract, fully funded and competitively won, offering predictable revenue through 2025. Key risks include the completion of Arctic Slope Technical Services' $388.5 million NASA contract (no future revenue) and fixed-price execution risk across multiple awards, particularly Suffolk Construction's $88.2 million VA boiler project. Investors should watch for option exercises on Merck's contracts and the re-compete of SENTURE's FMCSA work.

7 total filings
· daily

Federal IT & Cybersecurity Contracts — August 07, 2026

This digest covers a single $105.6 million civilian contract awarded to SENTURE LLC by the Department of Transportation's Federal Motor Carrier Safety Administration (FMCSA) for Customer Insurance and Registration Information Support (CIRIS) services. The contract is fully funded, runs through August 2025, and represents a long-term, predictable revenue stream for SENTURE. As a civilian agency award with no defense involvement, it highlights stable IT services demand outside the DoD. The highest-conviction signal is bullish, given the fully obligated funding and competitive award process, but the fixed-price structure introduces execution risk if costs overrun.

1 total filings
· daily

All HHS Contracts — August 07, 2026

Over a single-day period, HHS awarded two contracts totaling $392.2 million exclusively to Merck Sharp & Dohme LLC, with one contract classified as defense-related. The dominant theme is BARDA’s sustained investment in biodefense and pandemic preparedness, with both awards supporting pharmaceutical R&D and procurement. The highest-conviction signal is the $236.3 million cost-plus-fixed-fee contract, which provides low-risk, long-term revenue visibility through 2027. A key risk is the medium pricing risk on the $155.8 million firm-fixed-price ERVEBO contract, which could compress margins if production costs rise.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — August 07, 2026

This digest covers six mega contracts totaling $1.18 billion, with a clear civilian tilt (4 of 6 contracts) and a dominant theme of health security and IT modernization. The highest-conviction signal is Merck Sharp & Dohme's two HHS/BARDA awards totaling $392.2 million, reflecting sustained government investment in biodefense and pandemic preparedness. A key risk is the completed performance of the largest contract (Arctic Slope Technical Services, $388.5 million), which provides no future revenue. Investors should watch for option exercises on Merck's contracts and the re-compete of SENTURE's DOT award as near-term catalysts.

6 total filings
· daily

High-Value Federal Grants ($5M+) — August 07, 2026

This digest covers $1.26 billion in high-value federal grants and contracts, with a pronounced civilian tilt (5 of 7 awards) and a dominant theme of biodefense and pharmaceutical procurement via BARDA/HHS. The highest-conviction signal is Merck Sharp & Dohme's combined $392 million in two separate BARDA awards (one cost-plus, one firm-fixed-price for ERVEBO), reflecting sustained government commitment to pandemic preparedness and biodefense through 2034. A key risk is the concentration of awards to a single pharmaceutical entity (Merck) and the unknown competition status on the ERVEBO sole-source contract, which limits visibility into pricing power and margin durability. Defense-related contracts (2 of 7) are lower materiality and largely completed, offering limited forward-looking signals for the defense sector.

7 total filings
· daily

General Federal Contracts — August 07, 2026

This digest covers $1.26 billion in federal obligations across 7 contracts, with a pronounced civilian tilt (5 of 7 awards, 71% of total value) versus defense (2 awards, 16% of total). The dominant sector theme is health security and biodefense, driven by two Merck Sharp & Dohme contracts from HHS/BARDA totaling $392.1 million, signaling sustained government investment in pandemic preparedness and medical countermeasures post-COVID-19. The highest-conviction signal is Merck's dual BARDA wins, which provide long-term (10-year) revenue visibility with low pricing risk. A key risk is the concentration of obligations in completed or expiring contracts—$388.5 million from Arctic Slope Technical Services (NASA) and $108 million from Whitney Bradley & Brown (GSA) have already concluded performance periods, limiting future revenue contribution.

7 total filings
· daily

All NASA Contracts — August 07, 2026

This digest covers a single NASA contract totaling $388.5 million awarded to Arctic Slope Technical Services, Inc., an Alaskan Native Corporation-owned 8(a) firm. The contract is purely civilian (0% defense-related) and was executed under a cost-plus-fixed-fee structure from 2015 to 2022, providing low-risk, stable revenue during its performance period. The highest-conviction signal is the competitive moat provided by the 8(a) set-aside, though the contract's completion means no future revenue from this award. A key risk is the lack of follow-on contracts, which could indicate a gap in Arctic Slope's revenue pipeline.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 07, 2026

The 19 filings from the S&P 500 Technology sector reveal a heavy insider selling pattern across key names (Arista, Lam Research, Datadog), with most sales executed under Rule 10b5-1 plans, reducing alarm but signaling potential price ceiling concerns. KLA Corp's executive team collectively received large equity awards but also had significant shares withheld for taxes, a routine but large cash-out event. State Street Corporation filed passive 5%+ stakes in Adobe, Cisco, and Qualcomm, indicating broad institutional accumulation in mega-cap tech. No revenue, margin, or guidance data exists in these insider and beneficial ownership filings, so sector trends rely entirely on insider behavior. The dominant insider selling at Arista Networks ($102.7M total) from both CEO and 10% owner is the standout signal, especially given the company's recent performance and high valuation. The Lam Research CEO's $9M sale at $300, coupled with Lam's 10-K risk filing (medium risk/8 materiality), flags possible headwinds. Overall, the batch suggests a cautious tone among C-suite executives at high-growth names, with no bullish insider buying detected.

15 high priority 4 medium 19 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 07, 2026

This digest of 50 pre-analyzed regulatory filings for August 7, 2026, reveals a dominant theme of passive institutional position-taking, with State Street Corporation filing 35+ Schedule 13Gs disclosing new 5%+ stakes across a diverse set of sectors, including industrials, healthcare, technology, and energy. The most significant activist development is the consolidation of control at HWH International Inc. (84.7% ownership) via a share transfer agreement, and a notable accumulation by L1 Capital in Anteris Technologies Global Corp. (13.46% stake, up from 7.9%). Period-over-period comparisons are limited in these filings, but the volume of new 5%+ disclosures by State Street signals a broad, passive rebalancing or index-driven accumulation, not active stock-picking. The key actionable insight is the divergence between passive institutional flows and the few activist/event-driven situations, which offer higher potential for alpha generation. The overall sentiment is neutral, with no material guidance changes or insider trading activity reported in the batch, but the sheer scale of State Street's disclosures provides a macro-level view of institutional positioning.

4 high priority 46 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 07, 2026

The 12 filings from S&P 500 Financials constituents reveal a sector bifurcating between strong underwriting performance and headwinds from investment income and currency. AIG and Aflac both reported mixed quarters: AIG's net income fell 17% YoY despite 6% premium growth, while Aflac's earnings surged 38% YoY on improved investment results, though Japan premiums remain pressured by FX. Insider selling was notable, with senior executives at Marsh & McLennan and Intercontinental Exchange each liquidating over $1M in stock, signaling potential caution at current valuations. Capital allocation remains a key theme, with AIG returning $911M to shareholders in Q2 via buybacks and dividends, underscoring a commitment to shareholder returns despite earnings declines. The 13F filings from BlackRock, PNC, and American Express show routine portfolio disclosures with no material strategic shifts, while the Morgan Stanley CMBS 8-K is a non-material servicing change. The most actionable insights center on the divergence in earnings quality between AIG and Aflac, the insider selling pattern at MMC and ICE, and the governance upgrade at Travelers with the appointment of a seasoned CEO to its board.

6 high priority 6 medium 12 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 07, 2026

The 7 filings for the S&P 500 Energy sector on August 7, 2026, reveal a mixed picture of passive institutional positioning, director-level compensation, and a notable insider sale by Chevron's CEO. State Street Corp. disclosed significant passive stakes in Exxon Mobil (5%) and Expand Energy (6.5%), indicating continued institutional confidence in large-cap energy. Two Williams Companies directors received stock awards totaling ~$400K, a routine compensation event. The most actionable signal is Chevron CEO Michael Wirth's $1.04M stock sale, which, given his remaining modest holding of 26,308 shares, may raise questions about management's near-term conviction. A 10% owner of Texas Pacific Land Corp made a nominal purchase, likely a rounding adjustment. The Occidental Asset Management 13F is excluded as it is an asset manager filing, not an energy operating company. The lack of any period-over-period comparisons, forward-looking guidance, or capital allocation changes across these filings limits trend analysis, making insider activity the primary source of actionable intelligence.

4 high priority 3 medium 7 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 07, 2026

The 12 filings from the S&P 500 Industrials cohort on August 7, 2026, reveal a sector at an inflection point, characterized by aggressive capital deployment for growth and strategic repositioning. The most critical development is $Uber's massive $1.76B strategic bet on autonomous driving via Aurora Innovation, combined with a new acquisition Term Loan, signaling a pivotal shift towards next-gen mobility and a potential industry consolidation. Meanwhile, traditional industrial bellwethers show a stark contrast: $Republic Services exhibits solid revenue and cash flow growth but faces a troubling surge in equity method losses (from $2M to $58M), while $FedEx's COO conducted a substantial sell-off of 253,927 shares, introducing a bearish undercurrent to the logistics giant. A major passive signal emerged from $State Street, revealing 5%+ stakes in $ADP, $Cummins, and $Honeywell, indicating a 'buy-the-dip' or value rotation by a major institutional player in high-quality industrials. The sector is bifurcated between capital-intensive incumbents managing margin pressures and tech-forward companies pursuing high-risk, high-reward M&A and strategic investments. Capital allocation trends show $Republic boosting buybacks ($659M vs $59M YoY) and $General Dynamics promoting from within for board leadership, signaling internal confidence.

7 high priority 5 medium 12 total filings
· daily

US Material Events SEC 8-K Filings — August 07, 2026

The 50 filings reveal a dynamic market landscape with significant M&A activity, particularly in homebuilding (Dream Finders-Beazer) and Yum's strategic divestiture/acquisition of Pizza Hut China. Financial restructurings and capital raises are prominent, with QVC emerging from bankruptcy, Celestica raising $3.39B, and LCNB issuing subordinated notes. Several companies show strong operational performance, such as Dorchester Minerals (net income up 150% YoY) and Plains All American (Adjusted EBITDA up 10% YoY). However, governance and leadership changes are frequent, with notable CEO departures (Lightbridge) and auditor resignations (Canopy Growth). Sentiment is mixed across filings, with positive developments in M&A and growth offset by risks in post-bankruptcy entities and companies facing delisting (Barfresh). Overall, the market is experiencing a wave of strategic repositioning, capital optimization, and leadership transitions, creating both opportunities and risks for investors.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 07, 2026

This digest of 9 US SEC filings from August 7, 2026, reveals a surge in corporate distress signals across micro-cap stocks listed on the Nasdaq. A dominant theme is the widespread failure to maintain minimum bid prices and market value of listed securities (MVLS), with six out of nine filings (GIFTIFY, Avalanche, Neonode, Eightco, Barfresh, and Triller) directly addressing these deficiencies. This suggests a systemic liquidity and valuation crisis among companies with market caps likely below $50 million. More severe distress is evident in HeartSciences, which reported a critically low stockholders' equity of just $226,060 against a $2.5 million requirement and is tying its survival to an all-stock merger. The highest-risk event is NusaTrip's imminent delisting without appeal, linked to an SEC trading suspension and its majority owner's Chapter 11 bankruptcy. Period-over-period comparisons, while often unavailable due to 8-K filings, show deteriorating cash positions and mounting losses from annual reports, and a 'mixed' sentiment in Triller's filing underscores that compliance can be fragile. The aggregate intelligence points to a sector-wide shakeout where micro-cap companies are running out of financing options, with insider selling or silence and pending reverse split proposals adding further pressure. The key catalyst calendar is packed with compliance deadlines in early 2027, making these names high-risk, high-surveillance plays for distressed investors.

9 high priority 9 total filings
· daily

Global High-Priority Regulatory Events — August 07, 2026

This digest covers 50 filings from August 7, 2026, dominated by a wave of RBI regulatory actions tightening loan recovery practices across all Indian financial institutions, effective January 1, 2027, which will impose significant compliance costs and restrict aggressive recovery methods. The period is marked by a cluster of insolvency and restructuring events, including the near-total wipeout of KSS Ltd. shareholders (2.5% recovery for creditors) and the resolution of Bloom Dekor Ltd., alongside new CIRP admissions for Sun Granite Export Ltd. and ongoing distress at MTNL (₹9,574 crore default) and Videocon. M&A activity is notable, with Yum China's $1.2 billion Pizza Hut acquisition and Plains All American's transformative Canadian NGL sale driving strong Q2 earnings, while several small-cap companies like Kuber Udyog and Waaree Energies pursue strategic pivots. A significant red flag is the cluster of Nasdaq delisting notices for Eightco, Giftify, and Barfresh Food Group, all facing compliance deadlines in early 2027, signaling acute distress in micro-cap equities. Insider activity is limited but includes a small promoter buy at Glen Industries, while capital allocation trends show a focus on debt reduction (Plains) and strategic reinvestment (Raymond Realty, JK Tyre).

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 07, 2026

Today's digest is dominated by a major consolidation event in the homebuilding sector, with Dream Finders Homes acquiring Beazer Homes in a $2.2B all-cash deal, creating the sixth-largest U.S. homebuilder. This M&A activity overshadows a mixed earnings landscape where several companies (Natera, Monster Beverage, ACM Research) posted strong revenue growth, while others (Beazer, Sylvamo, Alpha Metallurgical) reported widening losses. A significant theme is the impact of non-recurring items, such as IEEPA tariff refunds boosting Interface's margins and tariff cost recovery aiding Under Armour's gross margin, masking underlying operational trends. The media sector shows stark contrasts, with Gray Media benefiting from a political ad surge while E.W. Scripps faces a massive goodwill impairment and a liquidity crunch. The day also features a flood of 13F filings from institutional investors, revealing a consensus overweight in mega-cap tech (NVIDIA, Apple, Microsoft) and a growing interest in defined-outcome ETFs and Bitcoin exposure, as seen in Palatine Hill's portfolio. Insider activity is limited, but a significant activist filing at Airwa Inc. signals potential governance changes. Overall, the data points to a market bifurcated between strong growth in niche areas (genetic testing, semiconductor equipment) and cyclical pressures in housing and traditional media, with capital allocation strategies favoring debt reduction and strategic M&A over aggressive buybacks.

14 high priority 36 medium 50 total filings